glp 1 for inflammation GLP-1 Receptor Agonists Reduce Low Dose GLP-1 for Inflammation:

Canada's Drug Agency has recommended that public plans cover Mounjaro with a discount of 25 to 49 per cent off list price at higher dosages [Source: theglobeandmail.com/business/economy/article-canada-drug-agency-mounjaro-recommendation-type-2-diabetes/]

Semaglutide is contraindicated in patients with personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2, though the relevance to humans remains uncertain

Einhorn D, Stewart DA, Erman MK, Gordon N, Philis-Tsimikas A, Casal E

Novo Nordisks newest drug, CagriSema, led to greater weight loss than semaglutide, according to results presented Sunday at the conference

This cellular response may eventually lead to the death of DA cells, leading to disease progression